Double Medical(002901) Zheng Quan Zhi Xing·2025-05-21 12:13Core Viewpoint - The legal opinion letter issued by Fujian Xinshi Law Firm confirms that the 2024 Annual General Meeting of Dahua Medical Technology Co., Ltd. is convened and conducted in compliance with relevant laws and regulations, ensuring the legality and validity of the meeting and its resolutions [1][13]. Group 1: Meeting Procedures - The meeting is scheduled for May 21, 2025, and the notice was published on April 24, 2025, on the designated information disclosure website [3][4]. - The meeting will utilize both on-site and online voting platforms, with specific time slots for each voting method [3][4]. Group 2: Attendance and Voting - A total of 7 shareholders attended the meeting, representing 347,095,811 shares, which accounts for 83.8356% of the total shares [4]. - The voting results for various proposals were reported, with significant support from shareholders, including small investors [8][9][10][11][12]. Group 3: Resolutions Passed - The following proposals were approved during the meeting: - 2024 Annual Board Work Report: 350,566,792 shares in favor, representing 84.6740% [7]. - 2024 Annual Supervisory Board Work Report: 350,566,792 shares in favor, representing 84.6740% [9]. - 2024 Annual Financial Settlement Report: 350,565,792 shares in favor, representing 84.6737% [10]. - 2024 Profit Distribution Proposal: 350,720,906 shares in favor, representing 84.7112% [11]. - 2024 Annual Report: 350,566,292 shares in favor, representing 84.6739% [12]. - Appointment of 2025 Audit Firm: 350,411,006 shares in favor, representing 84.6364% [12]. - 2025 Executive Compensation Assessment Method: 350,722,306 shares in favor, representing 84.7115% [12].